Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Zamarripa CA"" wg kryterium: Autor


Wyświetlanie 1-2 z 2
Tytuł:
The kappa-opioid receptor agonist, triazole 1.1, reduces oxycodone self-administration and enhances oxycodone-induced thermal antinociception in male rats.
Autorzy:
Zamarripa CA; Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, 2500 N. State Street, Jackson, MS, 39216, USA.
Pareek T; Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, 2500 N. State Street, Jackson, MS, 39216, USA.
Schrock HM; Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, 2500 N. State Street, Jackson, MS, 39216, USA.
Prisinzano TE; School of Pharmacy, University of Kentucky, Lexington, KY, USA.
Blough BE; Research Triangle Park, Durham, NC, USA.
Sufka KJ; Department of Psychology, University of Mississippi, Oxford, MS, USA.
Freeman KB; Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, 2500 N. State Street, Jackson, MS, 39216, USA. .
Pokaż więcej
Źródło:
Psychopharmacology [Psychopharmacology (Berl)] 2021 Dec; Vol. 238 (12), pp. 3463-3476. Date of Electronic Publication: 2021 Aug 25.
Typ publikacji:
Journal Article
MeSH Terms:
Oxycodone*/pharmacology
Receptors, Opioid, kappa*/agonists
Triazoles*/pharmacology
Nociception/*drug effects
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer ; Analgesics, Opioid/pharmacology ; Animals ; Dose-Response Relationship, Drug ; Male ; Rats ; Rats, Sprague-Dawley ; Receptors, Opioid, mu ; Self Administration
Czasopismo naukowe
Tytuł:
Kappa opioid agonists reduce oxycodone self-administration in male rhesus monkeys.
Autorzy:
Zamarripa CA; Division of Neurobiology and Behavior Research, Department of Psychiatry and Human Behavior, The University of Mississippi Medical Center, Jackson, MS, 39216, USA.
Naylor JE; Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.
Huskinson SL; Division of Neurobiology and Behavior Research, Department of Psychiatry and Human Behavior, The University of Mississippi Medical Center, Jackson, MS, 39216, USA.
Townsend EA; Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, 23298, USA.
Prisinzano TE; Department of Pharmaceutical Sciences, University of Kentucky, Lexington, KY, 40536, USA.
Freeman KB; Division of Neurobiology and Behavior Research, Department of Psychiatry and Human Behavior, The University of Mississippi Medical Center, Jackson, MS, 39216, USA. .
Pokaż więcej
Źródło:
Psychopharmacology [Psychopharmacology (Berl)] 2020 May; Vol. 237 (5), pp. 1471-1480. Date of Electronic Publication: 2020 Jan 31.
Typ publikacji:
Journal Article
MeSH Terms:
Analgesics, Opioid/*administration & dosage
Behavior, Addictive/*drug therapy
Diterpenes, Clerodane/*administration & dosage
Morphinans/*administration & dosage
Oxycodone/*administration & dosage
Receptors, Opioid, kappa/*agonists
Spiro Compounds/*administration & dosage
Animals ; Behavior, Addictive/psychology ; Cocaine/administration & dosage ; Dose-Response Relationship, Drug ; Macaca mulatta ; Male ; Naltrexone/administration & dosage ; Naltrexone/analogs & derivatives ; Narcotic Antagonists/administration & dosage ; Reinforcement, Psychology ; Self Administration
Czasopismo naukowe
    Wyświetlanie 1-2 z 2

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies